Journal of Experimental Medicine, Vol 167, 1560-1571, Copyright © 1988 by Rockefeller University Press

ARTICLES

A 52-kD protein is a novel component of the SS-A/Ro antigenic particle

E Ben-Chetrit, EK Chan, KF Sullivan and EM Tan
W. M. Keck Autoimmune Disease Center, Scripps Clinic and Research Foundation, La Jolla, California 92037.

Anti-SS-A/Ro autoantibodies are found in the sera of patients with Sjogren's syndrome (SS) and SLE. In the course of analyzing 61 SS patients for their autoantibody profiles, we found that 42 were positive for anti-SS-A by double diffusion in agarose and demonstrated precipitin lines identical to that produced by a prototype anti-SS-A serum. Further analysis of these SS-A antibody-positive sera by Western blotting of cell extracts revealed that 21 sera reacted with two proteins of 60 and 52 kD, 13 sera reacted with 52-kD protein, two detected only 60 kD, while six were nonreactive. Affinity-purified anti- 60-kD and anti-52-kD antibodies reacted exclusively with their corresponding antigens. Partial proteolysis of these proteins did not reveal common degradation fragments. Thus the 52- and 60-kD proteins were found to be antigenically and apparently structurally distinct from each other. They were also distinct from 48-kD SS-B/La protein. In immunoprecipitation using labeled cell extracts, affinity-purified anti- 52-kD antibodies brought down the 52-kD protein as well as the 60-kD band. In [32P]orthophosphate-labeled HeLa cell extract both antibodies precipitated the same spectrum of small RNAs (hYl-5). In indirect immunofluorescence, anti-52-kD and anti-60-kD antibodies immunolocalized in similar subcellular structures and showed similar punctate nuclear staining patterns. Western blot analysis revealed that both proteins were present in lymphocytic as well as epithelial human cell lines tested. The data above define a new antigen of 52 kD which is another component of the SS-A particle and is associated in complex formation with the previously reported 60-kD protein.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Hervier, B., Rimbert, M., Colonna, F., Hamidou, M. A., Audrain, M. (2009). Clinical significance of anti-Ro/SSA-52 kDa antibodies--a retrospective monocentric study. Rheumatology (Oxford) 48: 964-967 [Abstract] [Full Text]  
• Yoshimi, R., Chang, T.-H., Wang, H., Atsumi, T., Morse, H. C. III, Ozato, K. (2009). Gene Disruption Study Reveals a Nonredundant Role for TRIM21/Ro52 in NF-{kappa}B-Dependent Cytokine Expression in Fibroblasts. J. Immunol. 182: 7527-7538 [Abstract] [Full Text]  
• Keeble, A. H., Khan, Z., Forster, A., James, L. C. (2008). TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved. Proc. Natl. Acad. Sci. USA 105: 6045-6050 [Abstract] [Full Text]  
• Kong, H. J., Anderson, D. E., Lee, C. H., Jang, M. K., Tamura, T., Tailor, P., Cho, H. K., Cheong, J., Xiong, H., Morse, H. C. III, Ozato, K. (2007). Cutting Edge: Autoantigen Ro52 Is an Interferon Inducible E3 Ligase That Ubiquitinates IRF-8 and Enhances Cytokine Expression in Macrophages. J. Immunol. 179: 26-30 [Abstract] [Full Text]  
• James, L. C., Keeble, A. H., Khan, Z., Rhodes, D. A., Trowsdale, J. (2007). Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function. Proc. Natl. Acad. Sci. USA 104: 6200-6205 [Abstract] [Full Text]  
• Toker, E, Yavuz, S, Direskeneli, H (2004). Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjogren's syndrome. Br J Ophthalmol 88: 384-387 [Abstract] [Full Text]  
• Ishii, T., Ohnuma, K., Murakami, A., Takasawa, N., Yamochi, T., Iwata, S., Uchiyama, M., Dang, N. H., Tanaka, H., Morimoto, C. (2003). SS-A/Ro52, an Autoantigen Involved in CD28-Mediated IL-2 Production. J. Immunol. 170: 3653-3661 [Abstract] [Full Text]  
• Restivo, M., Kozhevnikov, D. O., Boutjdir, M. (2001). Optical mapping of activation patterns in an animal model of congenital heart block. Am. J. Physiol. Heart Circ. Physiol. 280: H1889-H1895 [Abstract] [Full Text]  
• Lock, R J, Unsworth, D J (2001). Antibodies to extractable nuclear antigens. Has technological drift affected clinical interpretation?. J. Clin. Pathol. 54: 187-190 [Abstract] [Full Text]  
• Pourmand, N., Wahren-Herlenius, M., Gunnarsson, I., Svenungsson, E., Löfström, B., Ioannou, Y., Isenberg, D. A, Magnusson, C. G M (1999). Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjogren's syndrome and systemic lupus erythematosus. Ann Rheum Dis 58: 623-629 [Abstract] [Full Text]  
• Rutjes, S. A., van der Heijden, A., Utz, P. J., van Venrooij, W. J., Pruijn, G. J. M. (1999). Rapid Nucleolytic Degradation of the Small Cytoplasmic Y RNAs during Apoptosis. J. Biol. Chem. 274: 24799-24807 [Abstract] [Full Text]  
• LaMorte, V. J., Dyck, J. A., Ochs, R. L., Evans, R. M. (1998). Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA 95: 4991-4996 [Abstract] [Full Text]  
• Viana, V S., Garcia, S, Nascimento, J H., Elkon, K B, Brot, N, Campos de Carvalho, A C, Bonfa, E (1998). Induction of in vitro heart block is not restricted to affinity purified anti-52 kDa Ro/SSA antibody from mothers of children with neonatal lupus. Lupus 7: 141-147 [Abstract]  
• Boutjdir, M., Chen, L., Zhang, * Z.-H., Tseng, C.-E, DiDonato, * F., Rashbaum, W., Morris, A., El-Sherif, N., Buyon, J. P. (1997). Arrhythmogenicity of IgG and Anti–52-kD SSA/Ro Affinity-Purified Antibodies From Mothers of Children With Congenital Heart Block. Circ. Res. 80: 354-362 [Abstract] [Full Text]  
• Lopez-Longo, F., Monteagudo, I., Gonzalez, C., Grau, R., Carreno, L. (1997). Systemic lupus erythematosus: clinical expression and anti-Ro/SS--A response in patients with and without lesions of subacute cutaneous lupus erythematosus. Lupus 6: 32-39 [Abstract]  
• Kawashima, T., Zappi, E. G., Lieu, T.-S., Sontheimer, R. D (1994). Impact of Ultraviolet Irradiation on Expression of SSA/Ro Autoantigenic Polypeptides in Transformed Human Epidermal Keratinocytes. Lupus 3: 493-500 [Abstract]  
• O'Brien, C A, Wolin, S L (1994). A possible role for the 60-kD Ro autoantigen in a discard pathway for defective 5S rRNA precursors.. Genes Dev. 8: 2891-2903 [Abstract]  
• Lee, L. A., Roberts, C. M., Frank, M. B., McCubbin, V. R., Reichlin, M. (1994). The Autoantibody Response to Ro/SSA in Cutaneous Lupus Erythematosus. Arch Dermatol 130: 1262-1268 [Abstract]  
• Lee, L. A., Reichlin, M., Ruyle, S. Z., Weston, W. L. (1993). Neonatal Lupus Liver Disease. Lupus 2: 333-338 [Abstract]  
• Meilof, J.F., Frohn-Mulder, Lm.E., Steward, P.A., Szatmari, A., Hess, J., Veldhoven, C.H.A., Smeenk, R.J.T., Swaak, A.J.G. (1993). Maternal Autoantibodies and Congenital Heart Block: No Evidence for the Existence of a Unique Heart Block-associated Anti-Ro/SS-A Autoantibody Profile. Lupus 2: 239-246 [Abstract]  
• Peek, R, Pruijn, G., van der Kemp, A., van Venrooij, W. (1993). Subcellular distribution of Ro ribonucleoprotein complexes and their constituents. J. Cell Sci. 106: 929-935 [Abstract]  
• Meilof, J.F., Frohn-Mulder, I.M.E., Steward, P.A., Szatmari, A., Hess, J., Veldhoven, C.H.A., Smeenk, R.J.T., Swaak, A.J.G. (1993). Maternal Autoantibodies and Congenital Heart Block: No Evidence for the Existence of a Unique Heart Block-associated Anti-Ro/SS-A Autoantibody Profile. Lupus 2: 239-246 [Abstract]  
• Fabini, G., Raijmakers, R., Hayer, S., Fouraux, M. A., Pruijn, G. J. M., Steiner, G. (2001). The Heterogeneous Nuclear Ribonucleoproteins I and K Interact with a Subset of the Ro Ribonucleoprotein-associated Y RNAs in Vitro and in Vivo. J. Biol. Chem. 276: 20711-20718 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS